Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6544
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis ; day:22 ; month:4 ; year:2016 ; pages:1-16
Cardiology and therapy ; (22.4.2016), 1-16
- Creator
-
Vallakati, Ajay
- Contributor
-
Sharma, Abhishek
Madmani, Mohammed
Reddy, Madhu
Kanmanthareddy, Arun
Gunda, Sampath
Lakkireddy, Dhanunjaya
Lewis, William R.
SpringerLink (Online service)
- DOI
-
10.1007/s40119-016-0061-7
- URN
-
urn:nbn:de:1111-2016042332006
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vallakati, Ajay
- Sharma, Abhishek
- Madmani, Mohammed
- Reddy, Madhu
- Kanmanthareddy, Arun
- Gunda, Sampath
- Lakkireddy, Dhanunjaya
- Lewis, William R.
- SpringerLink (Online service)
Other Objects (12)
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation
Incidental ablation of ganglionated plexus during atrial fibrillation ablation
Atrial fibrillation ablation in heart failure patients
Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Hybrid ablation for atrial fibrillation: a systematic review
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation
Incidental ablation of ganglionated plexus during atrial fibrillation ablation
Atrial fibrillation ablation in heart failure patients
Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Hybrid ablation for atrial fibrillation: a systematic review
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation
Incidental ablation of ganglionated plexus during atrial fibrillation ablation
Atrial fibrillation ablation in heart failure patients
Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Hybrid ablation for atrial fibrillation: a systematic review
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues